Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients

Author(s):
Broeyer, F.J.F.; Osanto, S.; Suzuki, J.; Jongh, F. de; Slooten, H. van; Tanis, B.C.; Bruning, T.; Bax, J.J.; Eck, H.J.R. van; Kam, M.L. de; Cohen, A.F.; Mituzhima, Y.; Burggraaf, J.
Published
2014
Publication type
Article / Letter to editor
anthracyclinesbiological markersbreast neoplasmselectrocardiographyheart failureoxidative stress
Date issued
2014-11-30
Language
English
Is part of
British Journal of Clinical Pharmacology (2014), Vol. 78, no. 5, p. 950-960
hdl
1887/103358
doi
10.1111/bcp.12429